吸烟对老年慢性阻塞性肺疾病患者ICS/LABA治疗疗效的影响
目的：观察吸烟对吸入性糖皮质激素联合长效β2受体激动剂（ICS/LABA）治疗中重度慢性阻塞性肺病（COPD）患者的影响。方法：选取2013年1月—2013年12月在复旦大学附属上海市第五人民医院老年呼吸科门诊和住院就诊的老年中、重度COPD稳定期患者,依照吸烟情况分为现吸烟组98例和曾吸烟组98例,两组患者均吸入福莫特罗/布地奈德,共治疗6个月。分别于治疗前和治疗3个月、6个月测定患者肺功能[第1秒用力呼气容积（FEV1）占预计值百分比、FEV1/用力肺活量（FVC）百分比],检测血中白细胞介素-8（IL-8）、肿瘤坏死因子-α（TNF-α）浓度,测定糖皮质激素受体（GR）-α和GR-β免疫...
Saved in:
| Published in | 中国临床医学 Vol. 23; no. 1; pp. 34 - 37 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
复旦大学附属上海市第五人民医院老年科,上海,200240%复旦大学附属上海市第五人民医院呼吸科,上海,200240
2016
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1008-6358 |
Cover
| Abstract | 目的：观察吸烟对吸入性糖皮质激素联合长效β2受体激动剂（ICS/LABA）治疗中重度慢性阻塞性肺病（COPD）患者的影响。方法：选取2013年1月—2013年12月在复旦大学附属上海市第五人民医院老年呼吸科门诊和住院就诊的老年中、重度COPD稳定期患者,依照吸烟情况分为现吸烟组98例和曾吸烟组98例,两组患者均吸入福莫特罗/布地奈德,共治疗6个月。分别于治疗前和治疗3个月、6个月测定患者肺功能[第1秒用力呼气容积（FEV1）占预计值百分比、FEV1/用力肺活量（FVC）百分比],检测血中白细胞介素-8（IL-8）、肿瘤坏死因子-α（TNF-α）浓度,测定糖皮质激素受体（GR）-α和GR-β免疫阳性外周血单个核细胞（PBMC）比例,并进行呼吸困难评分。结果：曾吸烟组、现吸烟组患者与治疗前相比,治疗3个月、6个月的FEV1%、FEV1/FVC%逐渐上升（P〈0.05）,呼吸困难评分逐渐下降（P〈0.05）;治疗后血中的TNF-α、IL-8水平逐渐下降（P〈0.05）;治疗前后外周血有核细胞GR-α阳性PBMC数无显著变化（P〉0.05）,曾吸烟组治疗6个月GR-β免疫阳性PBMC显著下降（P〈0.05）。与现吸烟组相比,曾吸烟组治疗3个月、6个月后FEV1%、FEV1/FVC%上升的幅度更大（P〈0.05）,呼吸困难评分下降幅度更大（P〈0.05）;曾吸烟组治疗3个月、6个月后TNF-α、IL-8下降幅度更大（P〈0.05）;曾吸烟组治疗3个月、6个月后GR-α阳性PBMC数上升的幅度更大,GR-β阳性PBMC数下降的幅度更大（P〈0.05）。结论：对现吸烟及曾吸烟的COPD患者,ICS/LABA都能够改善患者肺功能、缓解呼吸症状、减轻炎症反应、调节糖皮质激素受体。吸烟对ICS/LABA治疗COPD的疗效存在不良影响。 |
|---|---|
| AbstractList | R563; 目的：观察吸烟对吸入性糖皮质激素联合长效β2受体激动剂（ICS／LABA）治疗中重度慢性阻塞性肺病（COPD）患者的影响。方法：选取2013年1月—2013年12月在复旦大学附属上海市第五人民医院老年呼吸科门诊和住院就诊的老年中、重度COPD稳定期患者，依照吸烟情况分为现吸烟组98例和曾吸烟组98例，两组患者均吸入福莫特罗／布地奈德，共治疗6个月。分别于治疗前和治疗3个月、6个月测定患者肺功能[第1秒用力呼气容积（FEV1）占预计值百分比、FEV1／用力肺活量（FVC）百分比]，检测血中白细胞介素‐8（IL‐8）、肿瘤坏死因子‐α（TNF‐α）浓度，测定糖皮质激素受体（GR）‐α和GR‐β免疫阳性外周血单个核细胞（PBM C ）比例，并进行呼吸困难评分。结果：曾吸烟组、现吸烟组患者与治疗前相比，治疗3个月、6个月的FEV1％、FEV1／FVC％逐渐上升（P＜0．05），呼吸困难评分逐渐下降（P＜0．05）；治疗后血中的TNF‐α、IL‐8水平逐渐下降（P＜0．05）；治疗前后外周血有核细胞GR‐α阳性PBMC数无显著变化（P＞0．05），曾吸烟组治疗6个月GR‐β免疫阳性PBMC显著下降（P＜0．05）。与现吸烟组相比，曾吸烟组治疗3个月、6个月后FEV1％、FEV1／FVC％上升的幅度更大（P＜0．05），呼吸困难评分下降幅度更大（P＜0．05）；曾吸烟组治疗3个月、6个月后TNF‐α、IL‐8下降幅度更大（P＜0．05）；曾吸烟组治疗3个月、6个月后GR‐α阳性PBMC数上升的幅度更大，GR‐β阳性PBMC数下降的幅度更大（P＜0．05）。结论：对现吸烟及曾吸烟的COPD患者，ICS／LABA都能够改善患者肺功能、缓解呼吸症状、减轻炎症反应、调节糖皮质激素受体。吸烟对ICS／LABA治疗COPD的疗效存在不良影响。 目的：观察吸烟对吸入性糖皮质激素联合长效β2受体激动剂（ICS/LABA）治疗中重度慢性阻塞性肺病（COPD）患者的影响。方法：选取2013年1月—2013年12月在复旦大学附属上海市第五人民医院老年呼吸科门诊和住院就诊的老年中、重度COPD稳定期患者,依照吸烟情况分为现吸烟组98例和曾吸烟组98例,两组患者均吸入福莫特罗/布地奈德,共治疗6个月。分别于治疗前和治疗3个月、6个月测定患者肺功能[第1秒用力呼气容积（FEV1）占预计值百分比、FEV1/用力肺活量（FVC）百分比],检测血中白细胞介素-8（IL-8）、肿瘤坏死因子-α（TNF-α）浓度,测定糖皮质激素受体（GR）-α和GR-β免疫阳性外周血单个核细胞（PBMC）比例,并进行呼吸困难评分。结果：曾吸烟组、现吸烟组患者与治疗前相比,治疗3个月、6个月的FEV1%、FEV1/FVC%逐渐上升（P〈0.05）,呼吸困难评分逐渐下降（P〈0.05）;治疗后血中的TNF-α、IL-8水平逐渐下降（P〈0.05）;治疗前后外周血有核细胞GR-α阳性PBMC数无显著变化（P〉0.05）,曾吸烟组治疗6个月GR-β免疫阳性PBMC显著下降（P〈0.05）。与现吸烟组相比,曾吸烟组治疗3个月、6个月后FEV1%、FEV1/FVC%上升的幅度更大（P〈0.05）,呼吸困难评分下降幅度更大（P〈0.05）;曾吸烟组治疗3个月、6个月后TNF-α、IL-8下降幅度更大（P〈0.05）;曾吸烟组治疗3个月、6个月后GR-α阳性PBMC数上升的幅度更大,GR-β阳性PBMC数下降的幅度更大（P〈0.05）。结论：对现吸烟及曾吸烟的COPD患者,ICS/LABA都能够改善患者肺功能、缓解呼吸症状、减轻炎症反应、调节糖皮质激素受体。吸烟对ICS/LABA治疗COPD的疗效存在不良影响。 |
| Abstract_FL | Objective:To observe the effect of smoking on inhaled corticosteroids and long‐acting beta‐2 agonists (ICS/LABA) therapy for patients with moderate to severe chronic obstructive pulmonary disease (COPD) .Methods:Elderly patients with moderate to severe COPD in stable stage ,who consulted doctors at Department of Geriatric Respiratory Disease in our hospital or were admitted to our hospital during January 2013 and December 2013 ,were selected and allocated to smoking group (n=98) or ex‐smoker group(n=98) .All subjects were treated with inhaled formoterol and budesonide ,and the treatment lasted for 6 months .Before treatment and at the 3rd and 6th month of treatment ,pulmonary function (FEV1 pred% ,FEV1/FVC % ) , concentration of interleukin‐8(IL‐8) and tumor necrosis factor‐α(TNF‐α) in the blood ,and glucocorticoid receptor (GR)‐αand GR‐βpositive peripheral blood mononuclear cells (PBMC) were determined ,and meanwhile dyspnea score was evaluated . Results:In both smoking group and ex‐smoker group ,compared with that before treatment ,at the 3rd and 6th month of treatment ,the FEV1% and FEV1/FVC% gradually increased (P< 0 .05) ,dyspnea score decreased (P< 0 .05) .Blood concentrations of TNF‐α and IL‐8 decreased gradually after treatment (P< 0 .05) .The percentage of GR‐α positive PBMC didn’t change significantly (P>0 .05) ,while the percentage of GR‐βpositive PBMC decreased significantly at the 6th month of treatment in ex‐smoker group (P<0 .05) .Compared with that in smoking group ,FEV1% and FEV1/FVC% in ex‐smoker group increased more at the 3rd and 6th month of treatment ,while dyspnea score declined more (P< 0 .05) ,as well as the TNF‐αand IL‐8 (P< 0 .05) .At the 3rd and 6th month of treatment ,GR‐α positive PBMCs increased more in ex‐smoker group ,while GR‐βpositive PBMCs decreased more (P<0 .05) .Conclusions :For both smokers and ex‐smokers with CODP , ICS/LABA can improve pulmonary function , relieve respiratory symptoms , reduce inflammatory reaction , and regulate glucocorticoid receptor .Smoking has negative effect on ICS/LABA treatment . |
| Author | 谢娟 张莹 张山 施劲东 |
| AuthorAffiliation | 复旦大学附属上海市第五人民医院老年科,上海200240 复旦大学附属上海市第五人民医院呼吸科,上海200240 |
| AuthorAffiliation_xml | – name: 复旦大学附属上海市第五人民医院老年科,上海,200240%复旦大学附属上海市第五人民医院呼吸科,上海,200240 |
| Author_FL | ZHA NG Shan ZHANG Ying SHI Jin Dong XIE Juan |
| Author_FL_xml | – sequence: 1 fullname: XIE Juan – sequence: 2 fullname: ZHANG Ying – sequence: 3 fullname: ZHA NG Shan – sequence: 4 fullname: SHI Jin Dong |
| Author_xml | – sequence: 1 fullname: 谢娟 张莹 张山 施劲东 |
| BookMark | eNrjYmDJy89LZWHgNDQwsNA1Mza14GDgLS7OTDIwMDQwNTA2MuBk8Ho6Ycfz5vlP1-980dD4dOeWZ62LnjUsfzlj99OF84CMF027nk_b93x667OmxS8aWj2dg_V9HJ0cn23a_XzadCB6NrXj-ayWp3s3Pp3cy8PAmpaYU5zKC6W5GULcXEOcPXR9_N09nR19dJNNLS11TSxNkwyTEg2TE5MSjS3SLCxMUtJMLJPNUo1NzA1MgS61NDFNTEw2NjAxNDMwNDVONDM0NDdJNU1MtTA1sDRPNOZmUIcYW56Yl5aYlx6flV9alAe0ML4qPSe5ssLIAKQRaA5QpRJEZXJGfl56YSZQbUFRZm5iUWW8mZmFsYGFkamFMQBSw2s2 |
| ClassificationCodes | R563 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Effect of Smoking on ICS/LABA Therapy for Elderly Patients with COPD |
| DocumentTitle_FL | Effect of Smoking on ICS/LABA Therapy for Elderly Patients with COPD |
| EndPage | 37 |
| ExternalDocumentID | zglcyx201601009 668308258 |
| GrantInformation_xml | – fundername: 上海市闵行区自然科学研究课题 funderid: (编号2011MHZ12) |
| GroupedDBID | 2RA 92L ALMA_UNASSIGNED_HOLDINGS CDYEO CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| ID | FETCH-LOGICAL-c599-495b1ba1caba38f884df49c6e34705100945aac304160153a61174e5ae85097a3 |
| ISSN | 1008-6358 |
| IngestDate | Thu May 29 04:08:21 EDT 2025 Wed Feb 14 10:20:52 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 1 |
| Keywords | 慢性阻塞性肺疾病 吸入性糖皮质激素 长效β2受体激动剂 Chronic obstructive pulmonary disease Inhaled corticosteroids 吸烟 Long-acting beta-2 agonists Smoking |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c599-495b1ba1caba38f884df49c6e34705100945aac304160153a61174e5ae85097a3 |
| Notes | 31-1794/R Chronic obstructive pulmonary disease; Smoking; Inhaled corticosteroids; Long-acting beta-2 agonists Objective：To observe the effect of smoking on inhaled corticosteroids and long-acting beta-2 agonists（ICS/LABA）therapy for patients with moderate to severe chronic obstructive pulmonary disease（COPD）.Methods：Elderly patients with moderate to severe COPD in stable stage,who consulted doctors at Department of Geriatric Respiratory Disease in our hospital or were admitted to our hospital during January2013 and December 2013,were selected and allocated to smoking group（n=98）or ex-smoker group（n=98）.All subjects were treated with inhaled formoterol and budesonide,and the treatment lasted for 6months.Before treatment and at the 3rd and 6th month of treatment,pulmonary function（FEV1 pred%,FEV1/FVC %）,concentration of interleukin-8（IL-8）and tumor necrosis factor-α（TNF-α）in the blood,and glucocorticoid receptor（GR）-αand GR-βpositive peripheral blood mononuclear cells（PBMC）were determined,and meanwhile dyspnea s |
| PageCount | 4 |
| ParticipantIDs | wanfang_journals_zglcyx201601009 chongqing_primary_668308258 |
| PublicationCentury | 2000 |
| PublicationDate | 2016 |
| PublicationDateYYYYMMDD | 2016-01-01 |
| PublicationDate_xml | – year: 2016 text: 2016 |
| PublicationDecade | 2010 |
| PublicationTitle | 中国临床医学 |
| PublicationTitleAlternate | Chinese Journal Of Clinical Medicine |
| PublicationYear | 2016 |
| Publisher | 复旦大学附属上海市第五人民医院老年科,上海,200240%复旦大学附属上海市第五人民医院呼吸科,上海,200240 |
| Publisher_xml | – name: 复旦大学附属上海市第五人民医院老年科,上海,200240%复旦大学附属上海市第五人民医院呼吸科,上海,200240 |
| SSID | ssib001050320 ssib006562945 ssib036441625 ssib001103563 ssib002262996 ssib008144075 ssib051368386 |
| Score | 2.0445592 |
| Snippet | 目的：观察吸烟对吸入性糖皮质激素联合长效β2受体激动剂（ICS/LABA）治疗中重度慢性阻塞性肺病（COPD）患者的影响。方法：选取2013年1月—2013年12月在复旦大学附属上海市第... R563; 目的：观察吸烟对吸入性糖皮质激素联合长效β2受体激动剂（ICS／LABA）治疗中重度慢性阻塞性肺病（COPD）患者的影响。方法：选取2013年1月—2013年12月在复旦大学附属... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 34 |
| SubjectTerms | 吸入性糖皮质激素 吸烟 慢性阻塞性肺疾病 长效β2受体激动剂 |
| Title | 吸烟对老年慢性阻塞性肺疾病患者ICS/LABA治疗疗效的影响 |
| URI | http://lib.cqvip.com/qk/90920A/201601/668308258.html https://d.wanfangdata.com.cn/periodical/zglcyx201601009 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals issn: 1008-6358 databaseCode: DOA dateStart: 20160101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.doaj.org/ omitProxy: true ssIdentifier: ssib006562945 providerName: Directory of Open Access Journals |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFI-qnbggECDGAPXAO02BOIkd-5i0mcYEXCjSblU-uwPq-Ogk6KkMKnFBQkJsiAOfB44IxIExwX-TtvwXvOd0bQQIAVJlvTz72e_5uc7Pjj8M45xQCRcq9cxUytx04zQ3Y5W6ZpqzNI5tVzKH9g5fviJWr7lr63y9VntVWbW01YvPJ_3f7iv5H68iD_1Ku2T_wbOzTJGBNPoXQ_Qwhn_lYwg5KAsCCaEH0gG1Qhx_BQIFoaRFDJIRBx8DF0IBEmNtTVjgexAqUBKCQEsxUGElCsVtCHzKWQkIQk14lAOlscF3DorgFxtX0YZLPqXGpLbOUYuhwJzAkIPUuiofpKs1a0KgVVQOyGYVKUPokmF-U8cGlLLkBKUg5uATIRsHBjTBn00zkm6BpY3FGIk1s6ylGuBbWu8QK6XK4qRHwJa1mkKXxqkEtKYsVjWqEyTlzs1pb05rOxBRyV8actlbT6dRy_d-efbMT4dvCyHpPB9Ou8kRynmVMXs5nuZ0Af38mVkOF1V8JPB1P8d7CJ5tVfmMK-nT-hy_OQROxbyD5czB8vVtpTNT6AyQjc1u5yYiG73RrJtH3U4FE7WOGIeng5m6X7bMo0atv3HMWCsefx7ff1m835sM7hV7n0bDN6PBu-_P9ovXL5CYbH8Z73wb7w5H228ngyG2nQvUckYf98c7u_gbPX04fv6g-PqhePLouNFaCVuNVXN6Y4eZcEW3FfKYxRFLojhyZC6lm-auSkTmuB51_hbaHkWJY6GVCEOdSDAcEGc8yiTiVi9yThgL3c1udtKoZxFjuRe7IrETl0usROxQUgw9HGKkkbVoLM2qoX2jPJilPfPWolGfVkx7-ne93e53rid371ADsUiTU3_MYMk4RCnLubbTxkLv1lZ2BtFnLz6rW8APfyxlnA |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%90%B8%E7%83%9F%E5%AF%B9%E8%80%81%E5%B9%B4%E6%85%A2%E6%80%A7%E9%98%BB%E5%A1%9E%E6%80%A7%E8%82%BA%E7%96%BE%E7%97%85%E6%82%A3%E8%80%85ICS%2FLABA%E6%B2%BB%E7%96%97%E7%96%97%E6%95%88%E7%9A%84%E5%BD%B1%E5%93%8D&rft.jtitle=%E4%B8%AD%E5%9B%BD%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6&rft.au=%E8%B0%A2%E5%A8%9F+%E5%BC%A0%E8%8E%B9+%E5%BC%A0%E5%B1%B1+%E6%96%BD%E5%8A%B2%E4%B8%9C&rft.date=2016&rft.issn=1008-6358&rft.issue=1&rft.spage=34&rft.epage=37&rft.externalDocID=668308258 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F90920A%2F90920A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzglcyx%2Fzglcyx.jpg |